Results
1 -
4 of
4
(Click
here to explore results)
- Small molecule targeted therapies for endometrial cancer: progress, challenges, and opportunities. Fei-Fei Yang, Tian-Tian Zhao, Slieman Milaneh, Chun Zhang, Da-Jun Xiang, Wen-Long Wang
, RSC Med. Chem.
, 2024
- Recent biological applications of heterocyclic hybrids containing s-triazine scaffold. Muhammad Imran Ali, Muhammad Moazzam Naseer
, RSC Adv.
, 2023
, 13
, 30462
- The allosteric mechanism of mTOR activation can inform bitopic inhibitor optimization. Yonglan Liu, Mingzhen Zhang, Hyunbum Jang, Ruth Nussinov
, Chem. Sci.
, 2024
, 15
, 1003
- Second-generation tricyclic pyrimido-pyrrolo-oxazine mTOR inhibitor with predicted blood–brain barrier permeability. Chiara Borsari, Erhan Keles, Andrea Treyer, Martina De Pascale, Paul Hebeisen, Matthias Hamburger, Matthias P. Wymann
, RSC Med. Chem.
, 2021
, 12
, 579